1. Objectives {#sec1}
=============

The theme of the 17th Congress of the Japanese Society for Regenerative Medicine was 'The Integration of Wisdom from All Sectors.' This congress aimed to provide individuals from all relevant sectors --- including industry representatives, regulatory authorities, academics, and citizens --- with opportunities for exchanging views on regenerative medicine under one roof.

In general, there are various obstacles to applying new technologies to medicine, and the applications of more innovative technologies encounter larger and more numerous obstacles. Here is an example of conventional research and development (R&D): A patient with an intractable disease, longing for new strategies that can cure the disease, anticipates the development of such therapeutic strategies. A researcher who has developed a new technology believes that the (seed) technology can answer that patient\'s need and hopes that some companies will soon apply the technology to clinical settings. In contrast, companies are reluctant to work on clinical implementations of new technology because of its risk; regulatory authorities are even more reluctant to review new products, when no evaluation criteria have been set.

Thus, the conventional R&D lacks the concrete cooperation of all the stakeholders including patients, doctors, researchers, industries, regulatory authorities, and more. This results, in a sense, in 'relay-type' collaborations between academia and industries. After one sector hands over the baton to another sector, the former sector often does not care about what the latter subsequently does; the batons are often dropped. To avoid this situation, we need a platform for 'concurrent-type' collaborations, where all of the sectors (stakeholders) are involved from the early stage of the R&D. Such a platform would diminish discrepancies between needs and seeds, generate a strong synergy between all of the sectors, and even turn one sector\'s difficulties into another sector\'s opportunities, and thereby reduce the cost and time for the industrialization of the products.

We definitely need such an 'open innovation platform' to realize the industrialization of regenerative medicine, which is the most challenging medical technology. The Japanese Society for Regenerative Medicine is expected to take a lead in creating such a platform now more than ever; it will connect and involve people with various interests from all of the sectors in a transparent manner, and help them move forward hand-in-hand. The 17th Congress of the Japanese Society for Regenerative Medicine was designed to provide opportunities to contribute to an open innovation platform through lectures, symposia, scientific presentations, seminars, showcases, and personal interactions among stakeholders.

2. Participants {#sec2}
===============

There were 3860 participants in total. The congress had 3624 participants in the scientific sessions. The breakdown of the participants are as follows: 1796 general members, 258 graduate student members, 1324 non-members (1192 general and 132 graduate students), 142 junior-high-school, high-school, and undergraduate students, and 104 invitees. In addition, 236 students, teachers, and guardians joined the sessions for junior-high-school and high-school students (basic course, 107 students; advanced course, 34 students).

3. Lectures {#sec3}
===========

The congress offered one presidential lecture, one keynote lecture, one collaborative lecture by the Congress Chair and the Governor of Kanagawa Prefecture, and three special lectures.

As the president of the Japanese Society for Regenerative Medicine (JSRM), Dr. Yoshiki Sawa (Osaka University) delivered the presidential lecture entitled 'Developing Regenerative Medicine Universally' (Chairperson: Dr. Tsuyoshi Takato, JR Tokyo General Hospital). The lecture reviewed the efforts that the JSRM has made over the last five years in bringing domestic legislation on regenerative medicine to fruition. Dr. Sawa also provided an overview of the on-going project commissioned by the Japan Academy for Medical Research and Development (AMED), 'Formulation of Regenerative Medicine National Consortium Which Renders Nation-wide Assistance to Clinical Researches.' The project consists of the following three pillars, which will contribute to 'Developing Regenerative Medicine Universally': (1) technical support for regenerative medicine clinical researches, (2) the development of human resources for regenerative medicine, and (3) the management and operation of regenerative medicine clinical research data systems.

The keynote lecture was delivered by Dr. Toshiharu Furukawa, a member of the House of Councilors, Professor of Keio University, and Attorney-at-law at TMI Associates (Chairperson: Dr. Yoshiki Sawa, JSRM President, Osaka University). Dr. Furukawa\'s lecture, entitled 'Future of the Regenerative Medicine in Difficult Japanese Economic Situation' summarized the perspectives on the future of regenerative medicine, given the current status and future prediction of the economy and medical care cost, the progressive aging of the population, and legislation enacted or improved for regenerative medicine in Japan.

The Congress Chair Dr. Ung-il Chung/Yuichi Tei (The University of Tokyo) and the Governor of Kanagawa Prefecture Mr. Yuji Kuroiwa delivered a collaborative lecture. Dr. Tei first gave a lecture entitled 'The Integration of Wisdom from All Sectors: The Construction of an Open-innovation Platform.' He pointed out the drawbacks of conventional \'relay-type\' collaborations in the development and application of medical technology, proposing \'concurrent-type\' collaborations based on open-innovation platforms, on which people with various interests from all of the sectors are connected and involved in a transparent manner, acting together hand-in-hand. In his lecture entitled 'Kanagawa Vision for Industrialization on the Regenerative Medicine Field,' Governor Kuroiwa then overviewed 'Healthcare New Frontier Policy' that the Kanagawa Prefectural Government has been developing in order to extend its citizens\' healthy life expectancy and create new markets and industries. The policy integrates two approaches: (1) improvement of ME-BYO, a new concept that the individuals\' mental and physical conditions change continuously between healthy and sick states, and (2) the promotion of the social implementations of advanced medical technologies.

Three special lectures included 'Toward Social Implementation of Regenerative Medicine: Activities of Supporting Organizations' chaired by Dr. Yoshiki Sawa (JSRM President, Osaka University), 'KSSCR Presidential Session' chaired by Dr. Yoshiki Sawa, and 'Joint Session with TERMIS: Overview of TERMIS and TERMIS-AP Activities' chaired by Dr. Yasuhiko Tabata (Kyoto University). 'Toward Social Implementation of Regenerative Medicine: Activities of Supporting Organizations' provided the following four topics: 'State of the Industry' from Dr. Robert Preti (Alliance for Regenerative Medicine; Hitachi Chemical Advanced Therapeutics Solutions; Hitachi Chemical Regenerative Medicine Business Sector, USA), 'Academic Nation-wide Platform Which Delivers Regenerative Medicine to Bedside' from Dr. Yoshiki Sawa, 'UK Cell and Gene Therapy toward Commercialization' from Dr. Hidetoshi Hosoya (Cell and Gene Therapy Catapult, UK), and 'CCRM: A Collaborative Public/private Partnership Driving Commercialization in Regenerative Medicine' from Dr. Mitchel Sivilotti (Centre for Commercialization of Regenerative Medicine, Canada). In the 'KSSCR Presidential Session,' Dr. Youngsook Son (President of the Korean Society for Stem Cell Research; Department of Genetic Engineering and Graduate School of Biotechnology, Kyung Hee University; Institute of Regenerative Medicine, Kyung Hee University Hospital, Seoul, Korea) delivered the lecture entitled 'Trafficking of Endogenous Stem Cells for Tissue Repair.' In the 'Joint Session with TERMIS: Overview of TERMIS and TERMIS-AP Activities,' Dr. Gilson Khang (TERMIS Global Chair-Elect) summarized the history of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) and the activities of TERMIS-AP (Asia-Pacific Chapter).

4. The award lectures {#sec4}
=====================

The winners of the two JSRM Research Awards (clinical field and basic field), the JSRM Achievement Award, and the JSRM Johnson & Johnson Innovation Award gave short lectures about their achievements. The JSRM Research Awards were presented to Dr. Makoto Ikeya (Kyoto University) and Dr. Jun Takahashi (Kyoto University). The JSRM Achievement Award was presented to Dr. Mitsuo Ochi (Hiroshima University). The JSRM Johnson & Johnson Innovation Award was presented to Dr. Ryuji Kato (Nagoya University).

5. The symposia {#sec5}
===============

The Congress offered 43 concurrent symposia (235 talks in total) including two joint symposia with the Consortium for the Advancement of Animal Regenerative Medicine and the Japan Research Association for Immunotherapeutics. The titles, organizers, and members of the symposia are listed in [Table 1](#tbl1){ref-type="table"}. The symposia covered a broad spectrum of topics related to regenerative medicine: cutting-edge findings in stem cell biology, biotechnology, bioinformatics, and medicine; regenerative therapies and medical devices currently under development; the results and perspectives of clinically available products; regenerative therapies in veterinary medicine; regulatory science; the standardization and industrialization of regenerative medicine, and more. In addition, an evening session entitled 'The 1st Technology Auction in an Industry-Academia Collaboration for Regenerative Medicine' was a novel attempt to create innovations that will lead to social implementations of technologies by providing opportunities for collaborations between academia and industries.Table 1Symposia held in the 17th JSRM.Table 1No.TitleOrganizer \#1Organizer \#21Progress and Future of National Consortium for Regenerative MedicineYoshiki Sawa (Osaka University)Tsuyoshi Takato (JR Tokyo General Hospital)2Clinical application of regenerative therapy in musculoskeletal systemNorimasa Nakamura (Osaka Health Science University)Ichiro Sekiya (Tokyo Medical and Dental University)3Regeneration of liver: from mechanism analysis to therapy developmentGoshi Shiota (Tottori University)Yutaka Inagaki (Tokai University)4New way for the construction of human 3D tissueKoichi Nakayama (Saga University)Shin Enosawa (Keio University)5Perspective on regenerative medicine based on the core system for organismal homeostasisHayato Kaneda (Shiga University of Medical Science)Yo Mabuchi (Tokyo Medical and Dental University)6Progress and future perspective in cardiac regenerationKeiichi Fukuda (Keio University)Yuji Shiba (Shinshu University)7The forefront of periodontal regeneration therapyMasahiro Saito (Tohoku University)Shinya Murakami (Osaka University)8Cutting Edge in in-Body Tissue Architecture (iBTA) 2018Yasuhide Nakayama (National Cerebral and Cardiovascular Center)Ryuji Higashita (Yokohama General Hospital)9Biomaterial-Based Tissue EngineeringTakamasa Sakai (University of Tokyo)Taichi Ito (University of Tokyo)10Application of data science to regenerative medicineKohji Nishida (Osaka University)Ken-ichiro Hata (Japan Tissue Engineering Co., Ltd./Fujifilm Corporation)11Joint Symposium with Consortium for Advancement of Animal Regenerative Medicine: Current situation and future prospects in collaboration of industry, government and academia for development of animal regenerative medicineTakafumi Hamaoka (Research Institute for Animal Science in Biochemistry and Toxicology)Toshio Inaba (Osaka Prefecture University)12Regenerative medical application of genomic editing technologyAkitsu Hotta (Kyoto University)Erika Sasaki (Central Institute for Experimental Animals/Keio University)13Bridging between regenerative medicine and rehabilitationKazumi Kawahira (Laboratory of Repetitive facilitative exercise)Louis Yuge (Hiroshima University)14Impact of mechanical stimuli in regenerative medicine: Mechanobiology and mechanotherapyRei Ogawa (Nippon Medical School)Masahiro Sokabe (Nagoya University)15Elucidation of the mechanism of homeostasis and regeneration of skeletal muscle toward establishment of regenerative therapy for muscular dystrophiesHidetoshi Sakurai (Kyoto University)Yuko Miyagoe-Suzuki (National Center of Neurology and Psychiatry)16How do we operate cell processing facility in academia and in industry? -Current status and an issue to be resolved-Tomohiro Morio (Tokyo Medical and Dental University)Katsunori Tsuchiya (Dai Nippon Printing Co., Ltd)17Update summary of the analysis for the effect of mesenchymal stem cell.Shuji Terai (Niigata University)Shigeru Miyagawa (Osaka University)18Contribution of ceramic biomaterials in tissue engineering fieldKunio Ishikawa (Kyushu University)Osamu Suzuki (Tohoku University)19NIHS session: Forefront of method development for evaluating the quality and safety of cellular and tissue-based product.Yoji Sato (National Institute of Health Sciences)Yuji Haishima (National Institute of Health Sciences)20Efficient process for stem cell cultureYasuyuki Sakai (University of Tokyo)Masahiro Kino-oka (Osaka University)21Regenerative therapy based on biomimetics; endogenous stem cells and exosomesTakahiro Ochiya (National Cancer Center Research Institute)Mari Dezawa (Tohoku University)22Regenerative therapy in plastic and reconstructive surgeryTakashi Nakatsuka (Saitama Medical University)Kazuo Kishi (Keio University)23Preservation and banking of the products (human iPS-ES, a stem cell, a cell sheet, and a living body tissue, etc.) for regeneration medicineShokyu Gen (Suong-Hyu Hyon) (Kyoto Institute of Technology)Hiroshi Nagashima (Meiji University)24Japan-Korea Young Joint Symposium: Fusion of Biomaterials and Tissue Engineering for Regenerative MedicineMichiya Matsusaki (Osaka University)Takuya Matsumoto (Okayama University)25Basic and Clinic Researches in Veterinary Regenerative medicine ∼ Application for Small and Large Animal Practice, Stockbreeding, and Animal ProtectioñRyohei Nishimura (University of Tokyo)Shingo Hatoya (Osaka Prefecture University)26Next generation Informatics for regenerative medicineJun Sese (National Institute of Advanced Indusrial Science and Technology)Masaru Koido (Yokohama City University)27Innovation towards Gene and Cell TherapyTakashi Okada (Nippon Medical School)Hiroyuki Mizuguchi (Osaka University)28Issues observed during the development of regenerative medicine products by the developers with Sakigake Designation SchemeKen-ichiro Hata (Japan Tissue Engineering Co., Ltd./Fujifilm Corporation)Tadashi Sameshima (Terumo Corporation)29ISO standardization -- Novel driving force for regenerative medicine, orchestrating knowledge of industry, academia and governmentYutaka Yanagita (Astellas Pharma Inc.)Tatsuo Heki (Fujifilm Corporation)30Forefront of iPS cells and Clinical ResearchJun Takahashi (Kyoto University)Masayo Takahashi (RIKEN)31Cell Therapy in Office-based Physicians: Present and Future ChallengesYoshiyuki Aikawa (SBC medical group)Hiroshi Mizuno (Juntendo University)32Cutting edge of the regenerative medicine in the musculoskeletal systemMasaya Nakamura (Keio University)Noriyuki Tsumaki (Kyoto University)33Symposium held by Networking Conference for Promoting Regenerative Medicine in Dentisty Vol.2: Efforts for practical application and generalization of regenerative medicine in dentistryMasaki Honda (Aichi Gakuin University)Hayato Ohshima (Niigata University)34Public-private partnership for research on standardization and validation of methods for tumorigenicity assessment of regenerative medical products (MEASURE)Satoshi Yasuda (National Institute of Health Sciences)Keiji Yamamoto (Takeda Pharmaceutical Co., Ltd./FIRM-CoNCEPT)35Regenerative Therapy Clinically Applied in PatientsYasuhiko Tabata (Kyoto University)Noritaka Isogai (Kindai University)36Industry-government-academic alliance on regulatory science of regenerative medicinal productsKazuhiro Takekita (Osaka University)Akihiro Umezawa (National Research Institute for Child Health and Development)37"To build communication between regenerative medicine and society" produced by \"the Program for Developing Models of Risk Communication in Science and Technology (MEXT)\"Masayo Takahashi (RIKEN)Yoshimi Yashiro (Kyoto University)38Cell-based therapy in orthopaedic field -Current status in clinical application-Tomohiro Terao (Avenue Cell Clinic)Norimasa Nakamura (Osaka Health Science University)39The key of success in regenerative dentistry -Current status and future prospects of regenerative therapy in dental research-Yoshiyuki Yonehara (Nihon University)Masaki Honda (Aichi Gakuin University)40Exploring the possibilities of cell therapy using fetal appendage-derived cellsTokiko Nagamura-Inoue (University of Tokyo)Kenichi Yamahara (Hyogo College of Medicine)41Japan Research Association for Immunotherapeutics (JRAI) Joint Symposium: Challenge to overcome cancer-Advances in latest treatments-Tetsuya Nakatsura (National Cancer Center)Koji Tamada (Yamaguchi University)42New strategies of stem cell and cancer research by combination of the multicolor lineage tracing method and the multi-omics data analysisHiroo Ueno (Kansai Medical University)Itoshi Nikaido (RIKEN)43Conflict of interest for Regenerative MedicineKen-ichiro Hata (Japan Tissue Engineering Co., Ltd./Fujifilm Corporation)Shuji Terai (Niigata University)

6. The regular presentations (oral presentations and poster presentations) {#sec6}
==========================================================================

The regular presentations included 337 oral presentations and 358 poster presentations. The regular presentations were reviewed and selected by the program committee, based on their evaluation of the submitted abstracts. The oral presentations were classified into 59 sessions, each of which had four to seven presentations, depending on their topics as follows: pluripotent stem cells, somatic stem cells, cancer stem cells, mesenchymal cells, nervous system, heart, blood vessels, blood and bone marrow, respiratory system, digestive system, liver and pancreas, musculoskeletal system, urinary system, vision and hearing, oral tissues, skin, and tissue engineering.

The poster presentations were delivered in 43 sessions concerning the following topics: embryonic stem cells, induced pluripotent stem cells, somatic stem cells, cancer stem cells, mesenchymal cells, nervous system, heart, blood vessels, blood and bone marrow, respiratory system, digestive system, liver and pancreas, musculoskeletal system, vision and hearing, oral tissues, skin, tissue engineering, cell culture systems, and regulatory science. In both the oral and poster presentation sessions, moderators ensured that the sessions started and ended on time and facilitated questions and answers between the audience and the presenters.

7. Co-organized seminars {#sec7}
========================

The Congress provided 24 co-organized luncheon seminars and one morning seminar (35 talks in total). The seminars also covered a broad spectrum of topics related to regenerative medicine.

8. Sessions for junior high school and high school students {#sec8}
===========================================================

Two courses, basic and advanced, were offered. Students were registered before the Congress. In the basic course, Dr. Kohji Nishida (Osaka University) delivered a special lecture to the students. Students then made poster presentations on their findings obtained in their research activities at schools and discussed their findings with executive board members of the JSRM. Fourteen groups, including three groups of junior-high-school students, made presentations. The board members evaluated the presentations in terms of visibility of the poster, conciseness of the presentation, the originality and logic flow of the research, and the quality of the discussion. Based on the evaluation, two presentations were awarded a Gold medal, four were awarded a Silver medal, and eight were awarded a Bronze medal. Lastly, the students toured the 'State-of-the-Art Technology Showcase' to learn about various companies that work on regenerative medicine and their products. In addition to the students who joined the poster presentations, more than 60 students participated in the tour. The basic course was supervised by Dr. Kenji Ishihara (Ibaraki University) and Dr. Masahiro Kawakami (Nara Institute of Science and Technology).

In the advanced course, junior-high-school and high-school students were supposed to give oral presentations on a given theme: 'Current researches for stem cell and/or regenerative medicine + xxxx = yyyy. Create anything 'yyyy' that your group wants to realize for a new idea in the future by adding 'xxxx' to the current research.' The purpose of this theme was to give students the opportunity to learn current research and to expand the imagination for future research and career. Abstracts of the presentations were reviewed, and six groups were selected as participants. The oral presentations were evaluated by reviewers, and the groups that made distinguished presentations were awarded a Gold medal (one group), a Silver medal (two groups), and a Bronze medal (three groups). The presentation from the group that won a Gold medal was a proposal to regenerate hair that was lost in a side effect of medical treatment for childhood leukemia. In addition to the students\' presentations, three lectures were given by Dr. Masato Nakagawa (Kyoto University), Dr. Masayo Takahashi (RIKEN), and Dr. Takashi Yamamoto (Hiroshima University). The students also attended the collaborative lecture by the Congress Chair and the Governor of Kanagawa Prefecture. The advanced course was planned and executed by Dr. Kenji Ishihara (Ibaraki University) and Dr. Masahiro Kawakami (Nara Institute of Science and Technology).

These sessions were supported by the Japan Science and Technology Agency and General Incorporated Association 'Girl Power.'

9. The state-of-the-art technology showcase {#sec9}
===========================================

One hundred and fifty-eight organizations showcased their available products and technologies related to regenerative medicine at the State-of-the-Art Technology Showcase. They include laboratory equipment, chemicals, reagents, and systems used in clinical settings and research for regenerative medicine.

10. The Public program {#sec10}
======================

The public program was held on March 25th, 2018, with the theme 'How to Create a New Era.' The program, which was moderated by the Congress Chair Dr. Yuichi Tei, consisted of two sessions. In the first session, Dr. Atsuo Kishimoto (Osaka University) and Dr. Yoshimi Yashiro (Kyoto University) gave lectures. In the second session, three lectures were given by Dr. Takanori Takebe (Tokyo Medical and Dental University, Yokohama City University, Cincinnati Children\'s Hospital), Dr. Kaori Kuribayashi-Shigetomi (Hokkaido University), and Dr. Akira Watanabe (Kyoto University).

11. The organizers and program committee {#sec11}
========================================

Prof. Yuichi Tei served as the Congress Chair. Associate Prof. Shinsuke Ohba served as the secretary general and the chair of the program committee; Assistant Prof. Hironori Hojo served as the secretariat and the vice chair of the program committee. The members of the program committee were as follows (titles dispensed): Taichi Ito (The University of Tokyo), Hiroshi Egusa (Tohoku University), Susumu Eguchi (Nagasaki University), Hitoshi Okochi (Research Institute National Center for Global Health and Medicine), Shinsuke Ohba (The University of Tokyo), Koichi Omori (Kyoto University), Hideyuki Okano (Keio University), Kenji Osafune (Kyoto University), Hideaki Kagami (Matsumoto Dental University), Masahiro Kinooka (Osaka University), Taku Saito (The University of Tokyo), Masaharu Seno (Okayama University), Tsuyoshi Takato (JR Tokyo General Hospital), Jun Takahashi (Kyoto University), Mari Dezawa (Tohoku University), Norimasa Nakamura (Osaka Health Science University), Masaya Nakamura (Keio University), Keiichi Hishikawa (Keio University), Hironori Hojo (The University of Tokyo), Katsuhisa Matsuura (Tokyo Women\'s Medical University), Akifumi Matsuyama (National Institute of Biomedical Innovation), Atsushi Miyajima (The University of Tokyo), Tomohiro Morio (Tokyo Medical and Dental University), Tetsuji Yamaoka (National Cerebral and Cardiovascular Center), Seiichi Yokoo (Kyoto Prefectural University of Medicine), Kotaro Yoshimura (Jichi Medical University), and Shigeyuki Wakitani (Mukogawa Women\'s University).

12. Concluding remarks {#sec12}
======================

The 17th Congress of the Japanese Society for Regenerative Medicine had 3860 participants, and offered lectures and sessions with diverse but cutting-edge topics regarding the present state and future prospects of regenerative medicine. The organizers of the Congress hope that the participants from different sectors not only learned about the latest progress in regenerative medicine, but also took advantage of the opportunities to exchange views on this field. We also believe that synergy emerging from the congress will contribute to future social implementations of regenerative therapies that will cure diseases that have been treatment-resistant. We thank all of the participants, supporting organizations, and members of the program committee for their substantial contributions to this event.

Declaration of interest {#sec13}
=======================

The authors declare that they have no competing interests.

We thank Ms. Nozomi Nagumo, Mr. Kyosuke Mano, and Ms. Chizuru Kaieda for providing technical assistance.

Peer review under responsibility of the Japanese Society for Regenerative Medicine.
